939983-14-9 Usage
Uses
Used in Pharmaceutical Industry:
rel-2-[4-[[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)ethanone is used as a potential pharmaceutical candidate for [specific medical condition or application] due to its complex structure and the presence of various functional groups that may exhibit specific biological activities.
Used in Research and Development:
In the field of chemical research and development, rel-2-[4-[[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)ethanone serves as a valuable compound for studying its chemical properties, synthesis methods, and potential applications in various fields, including medicine, materials science, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 939983-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,9,8 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 939983-14:
(8*9)+(7*3)+(6*9)+(5*9)+(4*8)+(3*3)+(2*1)+(1*4)=239
239 % 10 = 9
So 939983-14-9 is a valid CAS Registry Number.
939983-14-9Relevant academic research and scientific papers
Discovery of RG7112: A small-molecule MDM2 inhibitor in clinical development
Vu, Binh,Wovkulich, Peter,Pizzolato, Giacomo,Lovey, Allen,Ding, Qingjie,Jiang, Nan,Liu, Jin-Jun,Zhao, Chunlin,Glenn, Kelli,Wen, Yang,Tovar, Christian,Packman, Kathryn,Vassilev, Lyubomir,Graves, Bradford
, p. 466 - 469 (2013/07/11)
The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress. It is controlled by its negative regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity. MDM2
4,4,5,5, Tetrasubstituted imidazolines
-
Page/Page column 14/1, (2008/06/13)
There is provided a compound of formula I and the pharmaceutically acceptable salts and esters thereof wherein X1, X2, R1, R2, R3, R4, R5 and R6 are herein described. The compounds exhibit activity as anticancer agents.
